Medifast
MED
247 hedge funds and large institutions have $1.41B invested in Medifast in 2018 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 90 increasing their positions, 79 reducing their positions, and 66 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 79
3.34% more ownership
Funds ownership: 91.36% → 94.7% (+3.3%)
7% more call options, than puts
Call options by funds: $11.7M | Put options by funds: $11M
7% less funds holding
Funds holding: 266 → 247 (-19)
27% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 66
42% less capital invested
Capital invested by funds: $2.42B → $1.41B (-$1B)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$27.1M |
| 2 |
Millennium Management
New York
|
+$16.3M |
| 3 |
Morgan Stanley
New York
|
+$15.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.6M |
| 5 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$11.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WG
Winton Group
London,
United Kingdom
|
-$13.7M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$13.4M |
| 3 |
Goldman Sachs
New York
|
-$11.8M |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
-$8.97M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$8.05M |
MED Hedge Fund Activity: Q4 2018 in Review
247 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2018, worth a combined $1.41B — down 42% from $2.42B a quarter earlier.
Sellers outnumbered buyers: 66 funds closed out of MED and 48 opened new positions — a net loss of 18 holders — while 79 trimmed existing stakes and 90 added.
The largest buyer was Jupiter Investment Management, adding an estimated $27.1M. The largest seller was Winton Group, cutting an estimated $13.7M.
- 247 institutional investors held Medifast (MED) as of Q4 2018, down from 266 in Q3 2018.
- Funds reported $1.41B of Medifast stock for Q4 2018, down 42% quarter-over-quarter.
- 48 funds opened new Medifast positions in Q4 2018 and 66 closed out, a net change of -18 holders.
- The largest Medifast buyer in Q4 2018 was Jupiter Investment Management, an estimated $27.1M added.
- The largest Medifast seller in Q4 2018 was Winton Group, an estimated $13.7M sold.
Based on aggregated 13F filings for Q4 2018.